For all sponsors, the challenge is patience. Biomedical research is an inherently high risk and lengthy process,

[Still,] the doubling over a decade of total spending by U.S. public and private research sponsors in real, inflation-adjusted terms should be reassuring to those who fear that financial sponsorship for research is not paralleling scientific opportunity, ... It is also reassuring that spending on health and biomedical science research by companies and government is not following reductions in research and development in other industries or reduced support for other areas of science.

When one adds art, one can reduce the overall risk to a portfolio by 10 percent to 20 percent.

Our preliminary research indicates that hybrid owners tend to fall into the preferred insured category, and at Travelers, lower risk drivers are rewarded with lower premiums. Additionally, hybrid vehicle sales have at least doubled every year since the first car was offered in the U.S. in 1999. This trend shows no signs of slowing, and Travelers intends to serve this growing market with innovative products to meet the changing needs of our customers.

It's hard to ask people who have been through so much for patience. But no one has ever done this before.

They are so incensed about the neglect, they risk getting caught themselves, ... This is not uncommon.